Quan Meina, Wang Xuechu, Gong Min, Wang Qi, Li Yan, Jia Jianping
Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, China.
National Medical Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, China.
Lancet Reg Health West Pac. 2023 Jul 5;38:100836. doi: 10.1016/j.lanwpc.2023.100836. eCollection 2023 Sep.
Post-COVID cognitive dysfunction (PCCD) is a condition in which patients with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, usually three months from the onset, exhibit subsequent cognitive impairment in various cognitive domains, and cannot be explained by an alternative diagnosis. While our knowledge of the risk factors and management strategy of PCCD is still incomplete, it is necessary to integrate current epidemiology, diagnosis and treatment evidence, and form consensus criteria to better understand this disease to improve disease management. Identifying the risk factors and vulnerable population of PCCD and providing reliable strategies for effective prevention and management is urgently needed. In this paper, we reviewed epidemiology, diagnostic markers, risk factors and available treatments on the disease, formed research recommendation framework for vulnerable population, under the background of post-COVID period.
新冠后认知功能障碍(PCCD)是一种疾病,患有严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染病史的患者,通常在发病三个月后,会在各个认知领域出现后续认知障碍,且无法用其他诊断来解释。虽然我们对PCCD的危险因素和管理策略的认识仍不完整,但有必要整合当前的流行病学、诊断和治疗证据,并形成共识标准,以更好地了解这种疾病,改善疾病管理。迫切需要确定PCCD的危险因素和易感人群,并提供有效的预防和管理可靠策略。在本文中,我们回顾了该疾病的流行病学、诊断标志物、危险因素和可用治疗方法,在新冠后时期的背景下,为易感人群形成了研究建议框架。